Organization
Osman Erganis
1 clinical trial
Clinical trial
Phase I Study Evaluating the Safety and Efficacy of the Protective Adjuvanted Inactivated Vaccine Developed Against SARS-CoV-2 in Healthy Participants, Administered as Two Injections Subcutaneously in Two Different Dosages.Status: Terminated, Estimated PCD: 2021-09-05